CatalystMarker
← board

DNABW

distress 1/10 · well-funded / low risk
$0.01today0% from 52w high
ginkgo.bio485 employeesFounded 2008Boston, MA
Revenue
$19M
Liquidity
$399M
Runway
2.4 yrs
Shares 1y
—

Overview

Volume
1.00K
52 Week Range
$0.01 – $0.01
Float Shares
47.85M
RVOL
1.00x
Beta
1.78

Pipeline · 0 trials · 0 upcoming

ReadoutPhaseDrugIndicationEnrollStatus
No pipeline trials tracked.

Catalyst news & presentations · 0

  • No catalyst news yet.

Approved drugs (0)

  • none — clinical-stage

Capital structure — dilution & financing

Shares out: — · 1 offerings/1y · 0 PIPEs
  • 2026-02-278-Kmaterial_agreement
  • 2025-09-048-Kmaterial_agreement
  • 2025-09-04424B5offering
  • 2025-08-14EFFECTshelf_effective
  • 2025-08-07S-3shelf_registration
  • 2024-11-14SC 13G/Astrategic_stake
  • 2024-11-12SC 13G/Astrategic_stake
🔒 Positioning — Pro
Short interest / days-to-cover, insider buys & sells.
Upgrade to Pro
🔒 Top holders — Pro
Institutional ownership + quarter-over-quarter accumulation/trimming.
Upgrade to Pro

Wall St ratings

no consensus
  • no recent rating changes

Competitors

  • none identified

Recent news

  • none

Not financial advice. Data: ClinicalTrials.gov, SEC EDGAR, FINRA, Nasdaq, Yahoo.